Stock Performance

GALT vs. S&P 500 | 2 Year Performance
GALT 1-Day Stock Chart
GALT 5-Day Stock Chart
GALT 1-Month Stock Chart
GALT 3-Month Stock Chart
GALT 6-Month Stock Chart
GALT 1-Year Stock Chart
GALT 2-Year Stock Chart
GALT 5-Year Stock Chart
View Interactive GALT Charts
Sponsored by

Key Data Points

Primary metrics and data points about Galectin Therapeutics Inc..
Current Price: $1.41
Prev Close: $1.45
Open: $1.45
Bid: $1.42
Ask: $3.40
Day's Range: $1.40 - $1.48
52wk Range: $1.08 - $4.11
Volume: 60,838
Avg Vol 153,282
Market Cap: $33.74M
P/E (ttm): -1.61
EPS (ttm): -$0.90
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Galectin Therapeutics Inc..
CAPS Rating 1 out of 5
48 Outperform
38 Underperform
CAPS All Stars
3 Outperform
25 Underperform

How do you think Galectin Therapeutics Inc. will perform against the market?

You pick for Galectin Therapeutics Inc. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

Business Summary

Industry, sector and description for Galectin Therapeutics Inc..

A development stage pharmaceutical company engaged in the discovery, development and commercialization of carbohydrate-based therapeutic compounds for advanced treatment of cancer, liver, microbial, cardiovascular and inflammatory diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers